Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress(R) 293 Adeno-Associated Virus Production Platform
By asianet
— Reduces process development time by an estimated 40 percent — Enables biopharmaceutical companies to increase the speed to clinical manufacturing — Adds to company’s best-in-class VirusExpress(R) Lentiviral Production Platform Merck, a leading science and technology company, has launched the VirusExpress(R) 293 Adeno-Associated Virus (AAV) Production Platform ( https://c212.net/c/link/?t=0&l=en&o=3615177-1&h=3615877518&u=http%3A%2F%2Femdmillipore.com%2FUS%2Fen%2F20200814_225427&a=VirusExpress%C2%AE+293+Adeno-Associated+Virus+(AAV)+Production+Platform ), making it one of the … Continued